FARMAKOTERAPIYa VESTIBULYaRNOGO GOLOVOKRUZhENIYa


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The article presents a review of modern methods of medical treatment of acute and chronic vestibular vertigo. The role of pharmacotherapy of the most common diseases of the vestibular system, such as benign paroxysmal positional vertigo, Meniere's disease, vestibular neuronitis, migraine-associated vertigo, is discussed. The most effective approaches to the symptomatic and pathogenetic treatment of vestibular disorders are considered.

全文:

受限制的访问

作者简介

M. Zamergrad

Email: zamergrad@gmail.com

参考

  1. Agrawal Y., Carey J.P., Della Santina C.C. Disorders of balance and vestibular function in US adults: data from the National Health and Nutrition Examination Survey, 2001-2004. Arch. Intern. Med. 2009; 169( 10):938-44.
  2. Neuhauser H.K., Lempert T. Vertigo: epidemiologic aspects. Semin. Neurol. 2009;29(5):473-81.
  3. Takeda N., Morita M., Hasegawa S., et al. Neurochemical mechanisms of motion sickness. Am. J. Otolaryngol. 1989;10:351-59.
  4. Storper I.S., Spitzer J.B., Scanlan M. Use of glycopyrrolate in the treatment of Meniere's disease. Laryngoscope. 1998; 108( 10): 1442-45.
  5. Brandt T. Vertigo. Its Multicensory Syndromes. London, 2000. 503 p.
  6. Rascol O., Hain T.C., Brefel C. Antivertigo medications and drug-induced vertigo. A pharmacological review. Drugs. 1995;50(5):777-91.
  7. Barone J.A. Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann. Pharmacother. 1999; 33:429-40.
  8. Venail F., Biboulet R., Mondain M. A protective effect of 5-HT3 antagonist against vestibular deficit? Metoclopramide versus ondansetron at the early stage of vestibular neuritis: A pilot study. Eur. Ann. Otorhinolaryngol. Head Neck Dis. 2012; 129(2):65-8.
  9. Dominguez M.O. Treatment and rehabilitation in vestibular neuritis. Rev. Laryngol. Otol. Rhinol. (Bord). 2005; 126:283-86.
  10. Cass S.P., Borello-France D., Furman J.M. Functional outcome of vestibular rehabilitation in patients with abnormal sensory-organization testing. Am. J. Otol. 1996; 17:581-94.
  11. Krebs D.E., Gill-Body K.M., Parker S.W., et al. Vestibular rehabilitation: useful but not universally so. Otolaryngol. Head Neck Surg. 2003;128:240-50.
  12. Topuz O., Topuz B., Ardic F.N., et al. Efficacy of vestibular rehabilitation on chronic unilateral vestibular dysfunction. Clin. Rehabil. 2004;18:76-83.
  13. Mira E., Guidetti G., Ghilardi L., et al. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo. Eur. Arch. Otorhinolaryngol. 2003; 260: 73-7.
  14. Oosterveld W.J. Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin. A double-blind placebo-controlled study. J. Laryngol. Otol. 1984; 98:37-41.
  15. Hamann K.F. Special ginkgo extract in cases of vertigo: a systematic review of randomised, double-blind, placebo controlled clinical examinations. HNO. 2007; 55:258-63.
  16. Orendors-Fraczkowska K., Pospiech L., Gawron W. Results of combined treatment for vestibular receptor impairment with physical therapy and Ginkgo biloba extract (Egb 761). Otolaryngol. Pol. 2002;56(1):83-8.
  17. Fernandes C.M., Samuel J. The use of piracetam in vertigo. S. Afr. Med. J. 1985; 68:806-08.
  18. Мельников О.А., Замерград М.В. Доброкачественное позиционное головокружение. Лечащий врач. 2000; 1:15-9.
  19. Herdman S.J. Treatment of benign paroxysmal vertigo. Phys. Ther. 1990;70;381-88.
  20. Korres S.G., Balatsouras D.G., Papouliakos S., Ferekidis E. Benign paroxysmal positional vertigo and its management. Med Sci Monit. 2007; 13:275-82.
  21. Пальчун В.Т., Кунельская Н.Л., Ротермел Е.В. Диагноз и лечение доброкачественного пароксизмального головокружения. Вест. оториноларингол. 2007;1:4-7.
  22. Guneri E.A., Kustutan O. The effects of betahistine in addition to epley maneuver in posterior canal benign paroxysmal positional vertigo. Otolaryngol. Head NeckSurg. 2012;146(1):104-08.
  23. Stambolieva K., Angov G. Effect of treatment with betahistine dihydrochloride on the postural stability in patients with different duration of benign paroxysmal positional vertigo. Int. Tinnitus J. 2010;16(1):32-6.
  24. Крюков А.И., Федорова О.К., Антонян Р.Г., Шеремет А.С. Клинические аспекты болезни Меньера. М., 2006. 239 с.
  25. Сагалович Б.М., Пальчун В.Т. Болезнь Меньера. М., 1999. 521 с.
  26. Gates G.A. Meniere's disease review 2005. J. Am. Acad. Audiol. 2006;17:16-6.
  27. Thirlwall A.S., Kundu S. Diuretics for Meniere's disease or syndrome. Cochrane Database Syst. Rev. 2006;19(3).
  28. Lezius F., Adrion C., Mansmann U., et al. High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Meniere's disease: a case series. Eur. Arch. Otorhinolaryngol. 2011;268(8):1237-40.
  29. Fishman J.M., Burgess C., Waddell A. Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis). Cochrane Database Syst. Rev. 2011 ;11:5.
  30. Crevits L., Bosman T. Migraine-related vertigo: towards a distinctive entity. Clin. Neurol. Neurosurg. 2005;107:82-7.
  31. Eggers S.D. Migraine-related vertigo: diagnosis and treatment. Curr. Pain Headache Rep. 2007; 11:217-26.
  32. Carmona S., Bruera O. Prophylatic treatment of migraine and migraine clinical variants with topiramate: an update. Ther. Clin. Risk Manag. 2009;5(3):661-69.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2014
##common.cookie##